These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 9416430

  • 1. Different TH2-TH1 balance in V beta 8 and V beta 6 subsets of splenocytes in NOD females in the early phase of diabetogenesis.
    Atlan-Gepner C, Hermitte L, Janand-Delenne B, Naquet P, Vialettes B.
    Diabetes Metab; 1997 Nov; 23(5):386-94. PubMed ID: 9416430
    [Abstract] [Full Text] [Related]

  • 2. Evidence for a preferential V beta usage by the T cells which adoptively transfer diabetes in NOD mice.
    Edouard P, Thivolet C, Bedossa P, Olivi M, Legrand B, Bendelac A, Bach JF, Carnaud C.
    Eur J Immunol; 1993 Mar; 23(3):727-33. PubMed ID: 8095459
    [Abstract] [Full Text] [Related]

  • 3. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS, Balasa B, Davies JD, Sarvetnick N.
    J Immunol; 1999 Aug 01; 163(3):1696-703. PubMed ID: 10415077
    [Abstract] [Full Text] [Related]

  • 4. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus.
    Hermitte L, Vialettes B, Naquet P, Atlan C, Payan MJ, Vague P.
    Eur J Immunol; 1990 Jun 01; 20(6):1297-303. PubMed ID: 2164479
    [Abstract] [Full Text] [Related]

  • 5. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse.
    Gombert JM, Herbelin A, Tancrède-Bohin E, Dy M, Carnaud C, Bach JF.
    Eur J Immunol; 1996 Dec 01; 26(12):2989-98. PubMed ID: 8977295
    [Abstract] [Full Text] [Related]

  • 6. Early defect of immunoregulatory T cells in autoimmune diabetes.
    Gombert JM, Herbelin A, Tancrède-Bohin E, Dy M, Chatenoud L, Carnaud C, Bach JF.
    C R Acad Sci III; 1996 Feb 01; 319(2):125-9. PubMed ID: 8680958
    [Abstract] [Full Text] [Related]

  • 7. Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model.
    Toyoda H, Formby B.
    Bioessays; 1998 Sep 01; 20(9):750-7. PubMed ID: 9819564
    [Abstract] [Full Text] [Related]

  • 8. T-cell receptor V region beta-chain gene expression in the autoimmune thyroiditis of non-obese diabetic mice.
    Matsuoka N, Bernard N, Concepcion ES, Graves PN, Ben-Nun A, Davies TF.
    J Immunol; 1993 Aug 01; 151(3):1691-701. PubMed ID: 8393051
    [Abstract] [Full Text] [Related]

  • 9. Immunopathogenic role of TH1 cells in autoimmune diabetes: evidence from a T1 and T2 doubly transgenic non-obese diabetic mouse model.
    Hung JT, Liao JH, Lin YC, Chang HY, Wu SF, Chang TH, Kung JT, Hsieh SL, McDevitt H, Sytwu HK.
    J Autoimmun; 2005 Nov 01; 25(3):181-92. PubMed ID: 16263243
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
    Moritani M, Yoshimoto K, Wong SF, Tanaka C, Yamaoka T, Sano T, Komagata Y, Miyazaki J, Kikutani H, Itakura M.
    J Clin Invest; 1998 Aug 01; 102(3):499-506. PubMed ID: 9691086
    [Abstract] [Full Text] [Related]

  • 13. Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice.
    Jaakkola I, Jalkanen S, Hänninen A.
    Eur J Immunol; 2003 Dec 01; 33(12):3255-64. PubMed ID: 14635033
    [Abstract] [Full Text] [Related]

  • 14. Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies.
    Serreze DV, Leiter EH.
    J Immunol; 1988 Jun 01; 140(11):3801-7. PubMed ID: 2897395
    [Abstract] [Full Text] [Related]

  • 15. IL-4-producing NK1.1+ T cells are resistant to glucocorticoid-induced apoptosis: implications for the Th1/Th2 balance.
    Tamada K, Harada M, Abe K, Li T, Nomoto K.
    J Immunol; 1998 Aug 01; 161(3):1239-47. PubMed ID: 9686584
    [Abstract] [Full Text] [Related]

  • 16. Sphingosine-1-phosphate reduces CD4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69.
    Srinivasan S, Bolick DT, Lukashev D, Lappas C, Sitkovsky M, Lynch KR, Hedrick CC.
    Diabetes; 2008 Feb 01; 57(2):484-93. PubMed ID: 18003758
    [Abstract] [Full Text] [Related]

  • 17. Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice.
    Pacheco-Silva A, Bastos MG, Muggia RA, Pankewycz O, Nichols J, Murphy JR, Strom TB, Rubin-Kelley VE.
    Eur J Immunol; 1992 Mar 01; 22(3):697-702. PubMed ID: 1547815
    [Abstract] [Full Text] [Related]

  • 18. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
    You S, Leforban B, Garcia C, Bach JF, Bluestone JA, Chatenoud L.
    Proc Natl Acad Sci U S A; 2007 Apr 10; 104(15):6335-40. PubMed ID: 17389382
    [Abstract] [Full Text] [Related]

  • 19. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H, Lieu YK, Noorchashm N, Rostami SY, Greeley SA, Schlachterman A, Song HK, Noto LE, Jevnikar AM, Barker CF, Naji A.
    J Immunol; 1999 Jul 15; 163(2):743-50. PubMed ID: 10395666
    [Abstract] [Full Text] [Related]

  • 20. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
    Chatenoud L.
    Novartis Found Symp; 2003 Jul 15; 252():279-86; discussion 286-90. PubMed ID: 14609225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.